High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke

Neurology

Volumn 71, Issue 23, 2008, Pages 1862-1868

  Castellanos, M ^a   Sobrino, T ^b   Pedraza, S ^a   Moldes, O ^b   Pumar, J M ^b   Silva, Y ^a   Serena, J ^a   Garcia Gil M ^a   Castillo, J ^b   Davalos A ^c  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; ARGININE; DESMOTEPLASE; GADOLINIUM PENTETATE; GLUTAMIC ACID; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE DURATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; BLOOD; CHI SQUARE DISTRIBUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE PROCESSING; MALE; METHODOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL; STROKE; TIME;

ARGININE; CEREBRAL INFARCTION; CHI-SQUARE DISTRIBUTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLUTAMIC ACID; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERLEUKIN-6; LINEAR MODELS; MALE; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149391821     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000326064.42186.7e     Document Type: Article

References (31)

1. Castillo J. Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. Cerebrovasc Dis 1999; 9(suppl 3):1-8.
2. Castillo J, Dávalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 1997;349:79-83.
3. Vila N, Castillo J, Dávalos A, Chamorro A. Proinflammatory cytokines in progressing ischemic stroke. Stroke 2000; 31:2325-2329.
4. Armengou A, Hurtado O, Leira R, et al. L-arginine levels in blood as a marker of nitric oxide mediated brain damage in acute stroke: a clinical and experimental study. J Cereb Blood Flow Metab 2003;23:978-984.
5. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute isch-emic stroke: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996;94:1167-1174.
6. Hacke W, Kaste M, Bogousslavsky J, et al. European Stroke Initiative Executive Committee and the EUSI Writing Committee: European Stroke Initiative Recom- mendations for Stroke Management: update 2003. Cere-brovasc Dis 2003;16:311-337.
7. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
8. Roberts C, Vermont J, Bosson JL. Formulas for threshold computations. Comput Biomed Res 1991;24:514-529.
9. Tsirka S, Rogove AD, Strickland S. Neuronal cell death and tPA. Nature 1996;384:123-124.
10. Nicole O, Docagne F, Ali C, et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 2001;7:59-64.
11. Takagi K, Ginsberg MD, Globus MY, et al. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab 1993;13:575-585.
12. Wang X, Shimizu-Sasamata M, Moskowithz MA, Newcomb R, Lo EH. Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice. Neurosci Lett 2001;313:121-124.
13. Hossman K-A. Periinfarct depolarizations. Cerebrovasc and Brain Metab Rev 1996;8:195-208.
14. Mies G, Iijima T, Hossmann K-A. Correlation between periinfarct DC shifts and ischemic neuronal damage in rat. Neuroreport 1993;4:709-711.
15. Mies G, Kohno K, Hossmann K-A. Prevention of periin-farct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J Cereb Blood Flow Metab 1994;14:802-807.
16. Gill R, Andine P, Hillered L, Persson L, Hagberg H. The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischemia in the rat. J Cereb Blood Flow Metab 1992;12:371-379.
17. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000;403:316-321.
18. Feustel PJ, Jin Y, Kimbelberg HK. Volume-regulated an-ion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke 2004;35:1164-1168.
19. Mallolas J, Hurtado O, Castellanos M, et al. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 2006;203:711-717.
20. Lin SZ, Chiou AL, Wang Y. Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats. Stroke 1996;27:747-752.
21. Iadecola C. Bright and dark sides of nitric oxide in isch-emic brain injury. Trends Neurosci 1997;20:132-139.
22. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
23. Forman LJ, Liu P, Nagele RG, Yin K, Wong PY. Augmentation of nitric oxide, superoxide, and perxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochem Res 1998;23:141-148.
24. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 1990;10:1035-1041.
25. Feuerstein GZ, Wang X, Barone FC. Inflammatory mediators and brain injury: the role of cytokines and chemokines in stroke and CNS diseases. In: Ginsberg MD, Bogousslavsky J, eds. Cere- brovascular Disease: Pathophysiology, diagnosis and Management. Boston, MA: Blackwell Science 1998;1:507-531.
26. Montaner J, Rovira A, Molina CA, et al. Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 2003;23:1403-1407.
27. Tarkowski E, Rosengren L, Blomstrand C, et al. Early in-trathecal production of interleukin-6 predicts the volume of brain lesion in stroke. Stroke 1995;26:1393-1398.
28. Vila N, Filella X, Deulofeu R, Ascaso C, Abellana R, Chamorro A. Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci 1999;162:185-188.
29. The National Institutes of Neurological Disorders, and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl j Med 1995;333: 1581-1587.
30. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34: 2729-2735.
31. Castillo J, Dávalos A, Naveiro J, Noya M. Neuroexcitatory aminoacids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27: 1060-1065.